Stratzy's Stock Idea: Buy Fortis Healthcare with Target Rs 780

On December 23, Stratzy issued a buy call on Fortis Healthcare, recommending investors purchase the stock. They set a target price of Rs 780, indicating a potential upside of 14.6% from the current market price of Rs 680.85. While the rationale behind this call was not specified, it is speculated that Stratzy anticipates positive financial performance or industry trends that could drive Fortis Healthcare's share price higher.

About Fortis Healthcare:

Fortis Healthcare Limited is a leading integrated healthcare services provider in India. It offers a wide range of healthcare services, including hospitals, diagnostics, and day care specialty facilities. With 36 hospitals, 31 diagnostics centers, and 4 day care specialty facilities across India, it offers comprehensive healthcare solutions to patients. The company's hospitals provide a full spectrum of medical services, ranging from primary care to super-specialties. Fortis Healthcare is committed to providing quality healthcare and patient-centric care.

52 Week Price Trend:

Fortis Healthcare, with a current market price of Rs 680.85, has experienced a range of price fluctuations over the past 52 weeks. The stock reached a high of Rs 740.35 and a low of Rs 375.05 during this period, indicating significant volatility. The current price falls within this range, suggesting that the stock is currently trading in a relatively neutral zone. Investors should carefully evaluate the company's financial performance, market conditions, and industry trends before making investment decisions.

Stratzy's MOST Analysis:

Fortis's AA rating from Stratzy's MOST framework reflects a positive assessment of the company's management, outlook, safety, and trend. This indicates a low fundamental risk, suggesting that Fortis is well-managed with a positive outlook, strong safety measures, and a favorable trend. The AA rating implies that investors perceive Fortis as a stable and financially sound company with a low risk of financial distress.

Company's Fundamentals:

Fortis Healthcare (NSE: FORTIS) is currently trading at a high stock PE ratio of 74.39, indicating that investors are willing to pay a premium for each rupee of earnings. The PB Ratio of 6.52 suggests that the company's market value is higher by 6.52 times its book value, implying that investors believe the company is undervalued. Despite these valuations, Fortis Healthcare offers a low dividend yield of 0.15%, which may not be attractive for income-oriented investors.

Fundamental and Technical information provided in this blog were last updated on 21 Dec, 2024

Disclaimer: The information and recommendations presented in this section, including any attached reports, are sourced from third-party providers through diverse channels. The views and opinions expressed within these materials belong solely to their respective creators. These views and opinions do not necessarily reflect the position of Stratzy Fintech Pvt Ltd. Stratzy explicitly disclaims any guarantees, express or implied, regarding the accuracy and reliability of the provided content. We strongly advise consulting with a licensed financial advisor before making any investment decisions based on this information. Remember, seeking independent financial advice is crucial.